The Asia Pacific Endovascular Aneurysm Repair Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
Endovascular aneurysm repair surgery is said to be a minimally invasive approach operation that can be conducted in an outpatient clinic or an ASC. Endovascular aneurysms develop when the arterial wall becomes compromised. Atherosclerosis, trauma, or infection can cause the wall to weaken or be injured. Other common causes of the same in old age include hereditary disorders. Thoracic aortic aneurysms cause a weakening in the blood vessels that supply the body with oxygen and nutrients. An aneurysm occurs when the vessel wall bulges like a balloon as a result of severe pressure.
The stent graft is removed from the catheter after it is put into an artery in the upper thigh and threaded to the abdominal aorta, allowing blood to flow through the aneurysm. Recently, clinical trials of non-invasive therapy of abdominal aortic aneurysms on the growing largest transverse diameter of doxycycline have been conducted at Stanford Healthcare.
There is an increase in the investment by the governments of the region on strengthening the regional healthcare system. It's because of recent developments in medical science, as well as the governing focus of regions like Korea and Japan, to oppose and quickly improve and produce new items within the EVAR spectrum. In addition, disease-causing factors like diabetes are on the rise. In India, for example, 77 million persons have diabetes mellitus, which is one of the most common causes of aneurysms. However, due to improvements in healthcare facilities, abundant disposable income, and rapid economic development, Asia-Pacific is likely to emerge as a lucrative region with the greatest growth potential.
The China market dominated the Asia Pacific Endovascular Aneurysm Repair Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $278.5 million by 2028. The Japan market is estimated to grow at a CAGR of 5% during (2022 - 2028). Additionally, The India market would display a CAGR of 6.3% during (2022 - 2028).
Based on Indication, the market is segmented into Abdominal and Thoratic. Based on Product, the market is segmented into Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, and Others. Based on Site, the market is segmented into Infrarenal and Pararenal. Based on Anatomy, the market is segmented into Traditional and Complex. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Endovascular Aneurysm Repair Market is Projected to reach USD 3.6 Billion by 2028, at a CAGR of 4.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Endologix LLC, Lombard Medical Limited, Cardinal Health, Inc., Becton, Dickinson and Company, Medtronic PLC, Cook Medical, Inc., Koninklijke Philips N.V., Terumo Corporation, Abbott Laboratories, and Artivion, Inc.
By Indication
By Product
By Site
By Anatomy
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
